Page last updated: 2024-09-03

sch 34826 and n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine

sch 34826 has been researched along with n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine in 1 studies

Compound Research Comparison

Studies
(sch 34826)
Trials
(sch 34826)
Recent Studies (post-2010)
(sch 34826)
Studies
(n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine)
Trials
(n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine)
Recent Studies (post-2010) (n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine)
312022505

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Innes, DG; Kavaliers, M1

Other Studies

1 other study(ies) available for sch 34826 and n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine

ArticleYear
Sex differences in the antinociceptive effects of the enkephalinase inhibitor, SCH 34826.
    Pharmacology, biochemistry, and behavior, 1993, Volume: 46, Issue:4

    Topics: Analgesia; Analgesics; Animals; Dioxolanes; Dipeptides; Enkephalin, Leucine; Female; Male; Naloxone; Naltrexone; Narcotic Antagonists; Neprilysin; Peromyscus; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Restraint, Physical; Sex Characteristics; Stress, Psychological

1993